AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 83 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,619 | -36.1% | 19,478 | +2.3% | 0.00% | – |
| Q2 2023 | $313,773 | +85.6% | 19,040 | +3.2% | 0.00% | – |
| Q1 2023 | $169,061 | +34.1% | 18,456 | +4.8% | 0.00% | – |
| Q4 2022 | $126,068 | +48.3% | 17,607 | +3.2% | 0.00% | – |
| Q3 2022 | $85,000 | +117.9% | 17,064 | +8.1% | 0.00% | – |
| Q2 2022 | $39,000 | -58.5% | 15,787 | +15.2% | 0.00% | – |
| Q1 2022 | $94,000 | +2.2% | 13,704 | +20.7% | 0.00% | – |
| Q4 2021 | $92,000 | -35.2% | 11,351 | -27.7% | 0.00% | – |
| Q1 2021 | $142,000 | +35.2% | 15,700 | 0.0% | 0.00% | – |
| Q4 2020 | $105,000 | +262.1% | 15,700 | +423.3% | 0.00% | – |
| Q1 2017 | $29,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |